Rosella Spadi
About
Rosella Spadi is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery.
According to data from OpenAlex, Rosella Spadi has authored 28 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 6 papers in Surgery. Recurrent topics in Rosella Spadi's work include Colorectal Cancer Treatments and Studies (7 papers), Pancreatic and Hepatic Oncology Research (7 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Rosella Spadi is often cited by papers focused on Colorectal Cancer Treatments and Studies (7 papers), Pancreatic and Hepatic Oncology Research (7 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Rosella Spadi collaborates with scholars based in Italy, United States and Malaysia. Rosella Spadi's co-authors include Alberto Zaniboni, Alfredo Falcone, Fotios Loupakis, Giuseppe Tonini, Chiara Cremolini, Sara Lonardi, Gianluca Masi, Luca Boni, Lisa Salvatore and Enrico Cortesi and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and PLoS ONE.
In The Last Decade
Rosella Spadi
27 papers receiving 1.4k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Rosella Spadi Italy | 13 | 1.1k | 489 | 358 | 324 | 218 | 28 | 1.4k | ||
| Silvia Mezi Italy | 15 | 1.0k 0.9× | 416 0.9× | 240 0.7× | 222 0.7× | 201 0.9× | 51 | 1.4k | ||
| Mashaal Dhir United States | 21 | 690 0.6× | 346 0.7× | 627 1.8× | 394 1.2× | 302 1.4× | 54 | 1.5k | ||
| Salvatore Artale Italy | 18 | 1.9k 1.8× | 648 1.3× | 780 2.2× | 183 0.6× | 252 1.2× | 41 | 2.3k | ||
| Janja Ocvirk Slovenia | 17 | 1.0k 0.9× | 376 0.8× | 231 0.6× | 226 0.7× | 117 0.5× | 69 | 1.3k | ||
| Claudia Maggi Italy | 21 | 873 0.8× | 360 0.7× | 259 0.7× | 157 0.5× | 301 1.4× | 36 | 1.3k | ||
| Tadamichi Denda Japan | 21 | 1.2k 1.1× | 646 1.3× | 382 1.1× | 202 0.6× | 296 1.4× | 130 | 1.5k | ||
| Cyril Hatem France | 4 | 823 0.8× | 238 0.5× | 365 1.0× | 657 2.0× | 187 0.9× | 5 | 1.3k | ||
| Javier Gállego Spain | 21 | 875 0.8× | 485 1.0× | 408 1.1× | 134 0.4× | 250 1.1× | 131 | 1.4k | ||
| Guy A. Van Hazel Australia | 18 | 1.9k 1.7× | 913 1.9× | 357 1.0× | 909 2.8× | 294 1.3× | 40 | 2.4k | ||
| G. Wilson United Kingdom | 16 | 1.5k 1.4× | 749 1.5× | 344 1.0× | 309 1.0× | 269 1.2× | 34 | 1.9k |
Countries citing papers authored by Rosella Spadi
Since
Specialization
Citations
This map shows the geographic impact of Rosella Spadi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosella Spadi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosella Spadi more than expected).
Fields of papers citing papers by Rosella Spadi
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Rosella Spadi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosella Spadi. The network helps show where Rosella Spadi may publish in the future.
Co-authorship network of co-authors of Rosella Spadi
This figure shows the co-authorship network connecting the top 25 collaborators of Rosella Spadi. A scholar is included among the top collaborators of Rosella Spadi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosella Spadi. Rosella Spadi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Astanina, Elena, Jasna Metović, Rosella Spadi, et al.. (2024). A neuroligin-2-YAP axis regulates progression of pancreatic intraepithelial neoplasia. EMBO Reports. 25(4). 1886–1908.
2.
Brugiapaglia, Silvia, Claudia Curcio, Maddalena Arigoni, et al.. (2024). In pancreatic cancer patients, chemotherapy reshapes the gene expression profile and antigen receptor repertoire of T lymphocytes and enhances their effector response to tumor-associated antigens. Frontiers in Immunology. 15. 1427424–1427424.
3.
Leone, Nicola, et al.. (2023). Colorectal cancer with synchronous unresectable liver metastases: resecting the primary tumor improves survival. International Journal of Colorectal Disease. 38(1). 169–169.
4.
Baratta, Francesca, Pietro Quaglino, Alessandro Comandone, et al.. (2022). Oncological patient management on the territory: The results of a survey in the north-west of Italy. Pharmacy Practice. 20(4). 1–9.
5.
Baratta, Francesca, Pietro Quaglino, Alessandro Comandone, et al.. (2022). The importance of a multidisciplinary care: community pharmacies as a hub to support oncologic patients with cutaneous reactions due to treatments. Italian Journal of Dermatology and Venereology. 156.
6.
Mandili, Giorgia, Giulio Ferrero, Hiroyuki Katayama, et al.. (2020). Immune-Complexome Analysis Identifies Immunoglobulin-Bound Biomarkers That Predict the Response to Chemotherapy of Pancreatic Cancer Patients. Cancers. 12(3). 746–746.
7.
Ferrero, Giulio, Giorgia Mandili, Marco Beccuti, et al.. (2019). Integrative Analysis of Novel Metabolic Subtypes in Pancreatic Cancer Fosters New Prognostic Biomarkers. Frontiers in Oncology. 9. 115–115.
8.
Peraldo‐Neia, Caterina, Giuliana Cavalloni, Elisabetta Fenocchio, et al.. (2018). Prognostic and predictive role of EGFR pathway alterations in biliary cancer patients treated with chemotherapy and anti-EGFR. PLoS ONE. 13(1). e0191593–e0191593.
9.
Martini, Stefania, Francesca Arcadipane, Paolo Strignano, et al.. (2018). Volumetric modulated arc therapy (VMAT) in the treatment of esophageal cancer patients. Medical Oncology. 35(12). 150–150.
10.
Franco, Pierfrancesco, Francesca Arcadipane, Paolo Strignano, et al.. (2017). Pre-operative treatments for adenocarcinoma of the lower oesophagus and gastro-oesophageal junction: a review of the current evidence from randomized trials. Medical Oncology. 34(3). 40–40.
11.
Spadi, Rosella. (2016). Current therapeutic strategies for advanced pancreatic cancer: A review for clinicians. World Journal of Clinical Oncology. 7(1). 27–27.
12.
Ponzetti, Agostino, Simone Ribero, Virginia Caliendo, et al.. (2016). Long-term survival after multidisciplinary management of a metastatic sarcomatoid porocarcinoma with repeated exeresis, radiotherapy, chemotherapy and cetuximab: case report and review of literature. Italian Journal of Dermatology and Venereology. 152(1). 66–70.
13.
Franco, Pierfrancesco, Massimiliano Mistrangelo, Francesca Arcadipane, et al.. (2015). Intensity-Modulated Radiation Therapy with Simultaneous Integrated Boost Combined with Concurrent Chemotherapy for the Treatment of Anal Cancer Patients: 4-Year Results of a Consecutive Case Series. Cancer Investigation. 33(6). 259–266.
14.
Cremolini, Chiara, Fotios Loupakis, Sara Lonardi, et al.. (2015). Early tumor shrinkage and depth of response predict long-term outcome in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab: results from phase III TRIBE trial by the Gruppo Oncologico del Nord Ovest. Annals of Oncology. 26(6). 1188–1194.
15.
Leone, Francesco, Donatella Marino, Roberto Filippi, et al.. (2015). A phase II, open-label, randomized clinical trial of panitumumab plus gemcitabine and oxaliplatin (GEMOX) versus GEMOX alone as first-line treatment in advanced biliary tract cancer: The Vecti-BIL study.. Journal of Clinical Oncology. 33(3_suppl). 281–281.
16.
Ponzetti, Agostino, Rosella Spadi, Laura Fanchini, et al.. (2015). Jaw Osteonecrosis associated with Aflibercept, Irinotecan and Fluorouracil: Attention to Oral District. Tumori Journal. 102(2_suppl). S74–S77.
17.
Loupakis, Fotios, Chiara Cremolini, Gianluca Masi, et al.. (2014). Initial Therapy with FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer. New England Journal of Medicine. 371(17). 1609–1618.
18.
Filippi, Andrea Riccardo, Serena Badellino, Manuela Ceccarelli, et al.. (2014). Stereotactic Ablative Radiation Therapy as First Local Therapy for Lung Oligometastases From Colorectal Cancer: A Single-Institution Cohort Study. International Journal of Radiation Oncology*Biology*Physics. 91(3). 524–529.
19.
Ponzetti, Agostino, Rosella Spadi, Laura Fanchini, et al.. (2013). Pilot Clinical Trial on the Efficacy of Prophylactic Use of Vitamin K1–Based Cream (Vigorskin) to Prevent Cetuximab-Induced Skin Rash in Patients With Metastatic Colorectal Cancer. Clinical Colorectal Cancer. 13(1). 62–67.
20.
Racca, Patrizia, Rosella Spadi, Laura Fanchini, et al.. (2011). Hemolytic uremic syndrome induced by infusion of oxaliplatin: A case report. Tumori Journal. 97(5). e31–e33.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Silvia Mezi Breakdown of academic impact, for papers by Mashaal Dhir Breakdown of academic impact, for papers by Salvatore Artale Breakdown of academic impact, for papers by Janja Ocvirk Breakdown of academic impact, for papers by Claudia Maggi Breakdown of academic impact, for papers by Tadamichi Denda Breakdown of academic impact, for papers by Cyril Hatem Breakdown of academic impact, for papers by Javier Gállego Breakdown of academic impact, for papers by Guy A. Van Hazel Breakdown of academic impact, for papers by G. Wilson